ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men

Clinical Science

Volumn 104, Issue 2, 2003, Pages 143-151

  Böhm, Felix ^a   Pernow, John ^a   Lindström, Jonas ^a   Ahlborg, Gunvor ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endothelin; Regional blood flow; Vascular resistance

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN RECEPTOR; OLIGOPEPTIDE; PIPERIDINE DERIVATIVE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL TONE; HUMAN; HUMAN EXPERIMENT; KIDNEY CIRCULATION; KIDNEY VASCULAR RESISTANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; SPLANCHNIC BLOOD FLOW; VASCULAR RESISTANCE; VASOCONSTRICTION; BLOOD; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; PHYSIOLOGY;

ADULT; BLOOD PRESSURE; DRUG SYNERGISM; ENDOTHELIN-1; HUMANS; MALE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RENAL CIRCULATION; SPLANCHNIC CIRCULATION; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 68649101075     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs1040143     Document Type: Article

References (39)

1. Yanagisawa, M., Kurihara, H., Kimura, S. et al. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London) 332, 411-415
2. Inoue, A., Yanagisawa, M., Kimura, S. et al. (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. U.S.A. 86, 2863-2867
3. Arai, S., Hori, S., Aramori, I., Ohkubo, H. and Nakanishi, S. (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature (London) 348, 730-732
4. Sakurai, T., Yanagisawa, M., Takuwat, Y. et al. (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (London) 348, 732-735
5. DeNucci, G., Thomas, R., D'Orleans-Juste, P. et al. (1988) Pressor effects of cirulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. U.S.A. 85, 9797-9800
6. Pernow, J., Kaijser, L., Lundberg, J. M. and Ahlborg, G. (1996) Comparable potent coronary vasoconstrictor effects of endothelin-1 and big endothelin-1 in humans. Circulation 94, 2077-2082
7. Weitzberg, E., Ahlborg, G. and Lundberg, J. M. (1991) Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues. Biochem. Biophys. Res. Commun. 180, 1298-1303
8. Pernow, J., Hemsen, A., Lundberg, J. M., Nowak, J. and Kaijser, L. (1991) Potent vasoconstrictor effects and clearance of endothelin in the human forearm. Acta Physiol. Scand. 141, 319-324
9. Haynes, W. G. and Webb, D. J. (1994) Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344, 852-854
10. Miyauchi, T. and Masaki, T. (1999) Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 61, 391-415
11. Kowala, M. C. (1997) The role of endothelin in the pathogenesis of atherosclerosis. Adv. Pharmacol. 37, 299-318
12. Ohta, K., Hirata, Y., Shichiri, M. et al. (1991) Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int. 39, 307-311
13. Lee, Y. J., Shin, S. J. and Tsai, J. H. (1994) Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 17, 263-266
14. Naicker, S. and Bhoola, K. D. (2001) Endothelins: vasoactive modulators of renal function in health and disease. Pharmacol. Ther. 90, 61-88
15. Cahill, P. A., Hou, M. C., Hendrickson, R. et al. (1998) Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: role in splanchnic hemodynamics. Hepatology 28, 396-403
16. Hasegawa, T., Kimura, T., Sasaki, T. and Okada, A. (2001) Plasma endothelin-1 level as a marker reflecting the severity of portal hypertension in biliary atresia. J. Pediatr. Surg. 36, 1609-1612
17. Fagan, K. A., McMurtry, I. F. and Rodman, D. M. (2001) Role of endothelin-1 in lung disease. Respir. Res. 2, 90-101
18. Rubens, C., Ewert, R., Halank, M. et al. (2001) Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 120, 1562-1569
19. King, A. J., Brenner, B. M. and Anderson, S. (1989) Endothelin: a potent renal and systemic vasoconstrictor peptide. Am. J. Physiol. 256, F1051-F1058
20. Rabelink, T. J., Kaasjager, K. A., Boer, P., Stroes, E. G., Braam, B. and Koomans, H. A. (1994) Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int. 46, 376-381
21. Hocher, B., Thone-Reineke, C., Rohmeiss, P. et al. (1997) Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J. Clin. Invest. 99, 1380-1389
22. Ottosson-Seeberger, A., Ahlborg, G., Hemsen, A., Lundberg, J. M. and Alvestrand, A. (1999) Hemodynamic effects of endothelin-1 and big endothelin-1 in chronic hemodialysis patients. J. Am. Soc. Nephrol. 10, 1037-1044
23. Böhm, F., Ahlborg, G., Johansson, B. L., Hansson, L. O. and Pernow, J. (2002) Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22, 674-679
24. Honing, M. L., Hijmering, M. L., Ballard, D. E. et al. (2000) Selective ET(A) receptor antagonism with ABT-627 attenuates all renal effects of endothelin in humans. J. Am. Soc. Nephrol. 11, 1498-1504
25. Ahlborg, G., Weitzberg, E. and Lundberg, J. M. (1995) Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans. J. Appl. Physiol. 79, 141-145
26. Cowburn, P. J., Cleland, J. G., McArthur, J. D., MacLean, M. R., McMurray, J. J. and Dargie, H. J. (1998) Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure. Lancet 352, 201-202
27. Strachan, F. E., Spratt, J. C., Wilkinson, I. B., Johnston, N. R., Gray, G. A. and Webb, D. J. (1999) Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension 33, 581-585
28. Hemsén, A., Larsson, O. and Lundberg, J. M. (1991) Characteristics of endothelin A and B binding sites and their vascular effects in pig peripheral tissues. Eur. J. Pharmacol. 208, 313-322
29. Ihara, M., Ishikawa, K., Fukuroda, T. et al. (1992) In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J. Cardiovasc. Pharmacol. 20 (Suppl. 12), S11-S14
30. Ishikawa, K., Ihara, M., Noguchi, K. et al. (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. U.S.A. 91, 4892-4896
31. Weitzberg, E., Ahlborg, G. and Lundberg, J. M. (1993) Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle. Clin. Physiol. 13, 653-662
32. Lehrke, I., Waldherr, R., Ritz, E. and Wagner, J. (2001) Renal endothelin-1 and endothelin receptor type b expression in glomerular diseases with proteinuria. J. Am. Soc. Nephrol. 12, 2321-2329
33. Fukuroda, T., Fujikawa, T., Ozaki, S., Ishikawa, K., Yano, M. and Nishikibe, M. (1994) Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem. Biophys. Res. Commun. 199, 1461-1465
34. Karet, F. E., Kuc, R. E. and Davenport, A. P. (1993) Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int. 44, 36-42
35. Yokomori, H., Oda, M., Yasogawa, Y. et al. (2001) Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver. Am. J. Pathol. 159, 1353-1362
36. Wang, H. G., Shibamoto, T. and Miyahara, T. (1997) Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver. Am. J. Physiol. 273, G1036-G1043
37. Verhaar, M. C., Strachan, F. E., Newby, D. E. et al. (1998) Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97, 752-756
38. Spratt, J. C., Goddard, J., Patel, N., Strachan, F. E., Rankin, A. J. and Webb, D. J. (2001) Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men. Br. J. Pharmacol. 134, 648-654
39. Burkhardt, M., Barton, M. and Shaw, S. G. (2000) Receptor- and non-receptor-mediated clearance of big-endothelin and endothelin-1: differential effects of acute and chronic ETA receptor blockade. J. Hypertens. 18, 273-279